BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8144852)

  • 1. Metyrapone induced increase in plasma corticotropin is not associated with changes in peripheral venous arginine vasopressin or corticotropin releasing factor.
    Holmes SJ; Florkowski CM; Evans MJ; Ellis MJ; Livesey JH; Donald RA; Espiner EA
    J Endocrinol Invest; 1993 Nov; 16(10):787-92. PubMed ID: 8144852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction.
    Donald RA; Crozier IG; Foy SG; Richards AM; Livesey JH; Ellis MJ; Mattioli L; Ikram H
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):499-504. PubMed ID: 8187316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL; Irvine CH; Livesey JH; Donald RA
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy.
    Florkowski CM; Crozier IG; Nightingale S; Evans MJ; Ellis MJ; Joyce P; Donald RA
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):163-8. PubMed ID: 8849570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adrenocorticotrophin, cortisol and aldosterone responses to ovine corticotrophin-releasing factor and vasopressin in sheep.
    Pradier P; Davicco MJ; Safwate A; Tournaire C; Dalle M; Barlet JP; Delost P
    Acta Endocrinol (Copenh); 1986 Jan; 111(1):93-100. PubMed ID: 3004095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metyrapone infusion on corticotropin-releasing factor and arginine vasopressin secretion into the hypophysial portal blood of conscious, unrestrained rams.
    Conte-Devolx B; Guillaume V; Boudouresque F; Graziani N; Magnan E; Grino M; Emperaire N; Nahoul K; Cataldi M; Oliver C
    Acta Endocrinol (Copenh); 1992 Nov; 127(5):435-40. PubMed ID: 1471455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man.
    Watabe T; Tanaka K; Kumagae M; Itoh S; Kogure M; Hasegawa M; Horiuchi T; Morio K; Takeda F; Ubukata E
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1132-7. PubMed ID: 2836468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin, and adrenocorticotropin as measured in pituitary venous blood from the horse.
    Alexander SL; Irvine CH; Ellis MJ; Donald RA
    Endocrinology; 1991 Jan; 128(1):65-72. PubMed ID: 1846116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma ACTH, AVP, CRH and catecholamine responses to conventional and laparoscopic cholecystectomy.
    Donald RA; Perry EG; Wittert GA; Chapman M; Livesey JH; Ellis MJ; Evans MJ; Yandle T; Espiner EA
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):609-15. PubMed ID: 8392916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor alone, but not arginine vasopressin alone, stimulates the release of adrenocorticotropin in the conscious intact sheep.
    McFarlane A; Coghlan J; Tresham J; Wintour EM
    Endocrinology; 1995 May; 136(5):1821-7. PubMed ID: 7720626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man.
    Ur E; Capstick C; McLoughlin L; Checkley S; Besser GM; Grossman A
    Neuroendocrinology; 1995 Feb; 61(2):191-7. PubMed ID: 7753338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man.
    Hensen J; Hader O; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1988 Apr; 66(4):668-71. PubMed ID: 2831245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.
    Salata RA; Jarrett DB; Verbalis JG; Robinson AG
    J Clin Invest; 1988 Mar; 81(3):766-74. PubMed ID: 2830315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of adrenocorticotropin and adrenal steroid responses to corticotropin-releasing hormone versus metyrapone testing in patients with hypopituitarism.
    Riddick L; Chrousos GP; Jeffries S; Pang S
    Pediatr Res; 1994 Aug; 36(2):215-20. PubMed ID: 7970937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discrepancy between plasma 11-deoxycortisol and ACTH concentrations in a single dose metyrapone test in normal men.
    Matsuki M; Nishida S; Horino M; Tenku A; Oyama H
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):62-5. PubMed ID: 6289591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
    Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.